The Needle-Free Drug Delivery Systems market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Needle-Free Drug Delivery Systems industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Needle-Free Drug Delivery Systems market can be split based on product types, major applications, and important countries as follows:
Key players in the global Needle-Free Drug Delivery Systems market covered in Chapter 12:
BD (
Crossject SA
Optinose, Inc
Zogenix, Inc
MedImmune, Inc
Mystic Pharmaceuticals, Inc
3M Pharmaceuticals
Injex Pharma AG
Antares Pharma, Inc.
Pharmajet, Inc
Valeritas, Inc
In Chapter 4 and 14.1, on the basis of types, the Needle-Free Drug Delivery Systems market from 2015 to 2025 is primarily split into:
Jet-based Needle-free Injectors
Spring-based Needle-free Injectors
Laser-based Needle-free Injectors
In Chapter 5 and 14.2, on the basis of applications, the Needle-Free Drug Delivery Systems market from 2015 to 2025 covers:
Insulin Needle-free Drug Delivery
Vaccine Needle-free Drug Delivery
Pediatric Needle-free Drug Delivery
Pain Needle-free Drug Delivery
Other Needle-free Drug Delivery
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Needle-Free Drug Delivery Systems Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of Needle-Free Drug Delivery Systems
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the Needle-Free Drug Delivery Systems industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global Needle-Free Drug Delivery Systems Market Size, 2015 - 2020
2.1.2 Global Needle-Free Drug Delivery Systems Market Size by Type, 2015 - 2020
2.1.3 Global Needle-Free Drug Delivery Systems Market Size by Application, 2015 - 2020
2.1.4 Global Needle-Free Drug Delivery Systems Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on Needle-Free Drug Delivery Systems Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of Needle-Free Drug Delivery Systems Analysis
3.2 Major Players of Needle-Free Drug Delivery Systems
3.3 Needle-Free Drug Delivery Systems Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of Needle-Free Drug Delivery Systems
3.3.3 Labor Cost of Needle-Free Drug Delivery Systems
3.4 Market Distributors of Needle-Free Drug Delivery Systems
3.5 Major Downstream Buyers of Needle-Free Drug Delivery Systems Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global Needle-Free Drug Delivery Systems Market, by Type
4.1 Global Needle-Free Drug Delivery Systems Value and Market Share by Type (2015-2020)
4.2 Global Needle-Free Drug Delivery Systems Production and Market Share by Type (2015-2020)
4.3 Global Needle-Free Drug Delivery Systems Value and Growth Rate by Type (2015-2020)
4.3.1 Global Needle-Free Drug Delivery Systems Value and Growth Rate of Jet-based Needle-free Injectors
4.3.2 Global Needle-Free Drug Delivery Systems Value and Growth Rate of Spring-based Needle-free Injectors
4.3.3 Global Needle-Free Drug Delivery Systems Value and Growth Rate of Laser-based Needle-free Injectors
4.4 Global Needle-Free Drug Delivery Systems Price Analysis by Type (2015-2020)
5 Needle-Free Drug Delivery Systems Market, by Application
5.1 Downstream Market Overview
5.2 Global Needle-Free Drug Delivery Systems Consumption and Market Share by Application (2015-2020)
5.3 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate of Insulin Needle-free Drug Delivery (2015-2020)
5.3.2 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate of Vaccine Needle-free Drug Delivery (2015-2020)
5.3.3 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate of Pediatric Needle-free Drug Delivery (2015-2020)
5.3.4 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate of Pain Needle-free Drug Delivery (2015-2020)
5.3.5 Global Needle-Free Drug Delivery Systems Consumption and Growth Rate of Other Needle-free Drug Delivery (2015-2020)
6 Global Needle-Free Drug Delivery Systems Market Analysis by Regions
6.1 Global Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Regions
6.1.1 Global Needle-Free Drug Delivery Systems Sales by Regions (2015-2020)
6.1.2 Global Needle-Free Drug Delivery Systems Revenue by Regions (2015-2020)
6.2 North America Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
6.3 Europe Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
6.6 South America Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
7 North America Needle-Free Drug Delivery Systems Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Countries
7.2.1 North America Needle-Free Drug Delivery Systems Sales by Countries (2015-2020)
7.2.2 North America Needle-Free Drug Delivery Systems Revenue by Countries (2015-2020)
7.3 United States Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
7.4 Canada Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
7.5 Mexico Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8 Europe Needle-Free Drug Delivery Systems Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Countries
8.2.1 Europe Needle-Free Drug Delivery Systems Sales by Countries (2015-2020)
8.2.2 Europe Needle-Free Drug Delivery Systems Revenue by Countries (2015-2020)
8.3 Germany Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8.4 UK Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8.5 France Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8.6 Italy Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8.7 Spain Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
8.8 Russia Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9 Asia Pacific Needle-Free Drug Delivery Systems Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific Needle-Free Drug Delivery Systems Sales by Countries (2015-2020)
9.2.2 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Countries (2015-2020)
9.3 China Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9.4 Japan Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9.5 South Korea Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9.6 India Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9.7 Southeast Asia Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
9.8 Australia Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
10 Middle East and Africa Needle-Free Drug Delivery Systems Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Countries (2015-2020)
10.2.2 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Countries (2015-2020)
10.3 Saudi Arabia Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
10.4 UAE Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
10.5 Egypt Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
10.6 Nigeria Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
10.7 South Africa Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
11 South America Needle-Free Drug Delivery Systems Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America Needle-Free Drug Delivery Systems Sales, Revenue and Market Share by Countries
11.2.1 South America Needle-Free Drug Delivery Systems Sales by Countries (2015-2020)
11.2.2 South America Needle-Free Drug Delivery Systems Revenue by Countries (2015-2020)
11.3 Brazil Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
11.4 Argentina Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
11.5 Columbia Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
11.6 Chile Needle-Free Drug Delivery Systems Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 BD (
12.1.1 BD ( Basic Information
12.1.2 Needle-Free Drug Delivery Systems Product Introduction
12.1.3 BD ( Production, Value, Price, Gross Margin 2015-2020
12.2 Crossject SA
12.2.1 Crossject SA Basic Information
12.2.2 Needle-Free Drug Delivery Systems Product Introduction
12.2.3 Crossject SA Production, Value, Price, Gross Margin 2015-2020
12.3 Optinose, Inc
12.3.1 Optinose, Inc Basic Information
12.3.2 Needle-Free Drug Delivery Systems Product Introduction
12.3.3 Optinose, Inc Production, Value, Price, Gross Margin 2015-2020
12.4 Zogenix, Inc
12.4.1 Zogenix, Inc Basic Information
12.4.2 Needle-Free Drug Delivery Systems Product Introduction
12.4.3 Zogenix, Inc Production, Value, Price, Gross Margin 2015-2020
12.5 MedImmune, Inc
12.5.1 MedImmune, Inc Basic Information
12.5.2 Needle-Free Drug Delivery Systems Product Introduction
12.5.3 MedImmune, Inc Production, Value, Price, Gross Margin 2015-2020
12.6 Mystic Pharmaceuticals, Inc
12.6.1 Mystic Pharmaceuticals, Inc Basic Information
12.6.2 Needle-Free Drug Delivery Systems Product Introduction
12.6.3 Mystic Pharmaceuticals, Inc Production, Value, Price, Gross Margin 2015-2020
12.7 3M Pharmaceuticals
12.7.1 3M Pharmaceuticals Basic Information
12.7.2 Needle-Free Drug Delivery Systems Product Introduction
12.7.3 3M Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.8 Injex Pharma AG
12.8.1 Injex Pharma AG Basic Information
12.8.2 Needle-Free Drug Delivery Systems Product Introduction
12.8.3 Injex Pharma AG Production, Value, Price, Gross Margin 2015-2020
12.9 Antares Pharma, Inc.
12.9.1 Antares Pharma, Inc. Basic Information
12.9.2 Needle-Free Drug Delivery Systems Product Introduction
12.9.3 Antares Pharma, Inc. Production, Value, Price, Gross Margin 2015-2020
12.10 Pharmajet, Inc
12.10.1 Pharmajet, Inc Basic Information
12.10.2 Needle-Free Drug Delivery Systems Product Introduction
12.10.3 Pharmajet, Inc Production, Value, Price, Gross Margin 2015-2020
12.11 Valeritas, Inc
12.11.1 Valeritas, Inc Basic Information
12.11.2 Needle-Free Drug Delivery Systems Product Introduction
12.11.3 Valeritas, Inc Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Needle-Free Drug Delivery Systems Market Forecast
14.1 Global Needle-Free Drug Delivery Systems Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Jet-based Needle-free Injectors Market Value and Volume Forecast (2020-2025)
14.1.2 Spring-based Needle-free Injectors Market Value and Volume Forecast (2020-2025)
14.1.3 Laser-based Needle-free Injectors Market Value and Volume Forecast (2020-2025)
14.2 Global Needle-Free Drug Delivery Systems Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Insulin Needle-free Drug Delivery Market Value and Volume Forecast (2020-2025)
14.2.2 Vaccine Needle-free Drug Delivery Market Value and Volume Forecast (2020-2025)
14.2.3 Pediatric Needle-free Drug Delivery Market Value and Volume Forecast (2020-2025)
14.2.4 Pain Needle-free Drug Delivery Market Value and Volume Forecast (2020-2025)
14.2.5 Other Needle-free Drug Delivery Market Value and Volume Forecast (2020-2025)
14.3 Needle-Free Drug Delivery Systems Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter